Packard Completes Sale of Canberra | GenomeWeb

NEW YORK, Feb 27 - Packard BioScience said Tuesday it completed the sale of its nuclear products division, Canberra Industries, to Cogema of France.

Cogema bought Canberra for $170 million. Packard of Meriden, Conn.,  has said it would use the proceeds of the sale for debt repayment, research and development, and general purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.